Invention Grant
- Patent Title: Hydrophilic fluorinated molecules for liposomal 19F MRI probes with unique MR signatures
-
Application No.: US15827782Application Date: 2017-11-30
-
Publication No.: US11241510B2Publication Date: 2022-02-08
- Inventor: Ananth Annapragada , Eric A. Tanifum
- Applicant: TEXAS CHILDREN'S HOSPITAL
- Applicant Address: US TX Houston
- Assignee: TEXAS CHILDREN'S HOSPITAL
- Current Assignee: TEXAS CHILDREN'S HOSPITAL
- Current Assignee Address: US TX Houston
- Agency: Norton Rose Fulbright US LLP
- Main IPC: A61K51/00
- IPC: A61K51/00 ; A61M36/14 ; A61K51/04 ; A61K49/10 ; A61K49/12 ; A61K49/18 ; A61K51/12

Abstract:
Readily available hydrophilic and small organofluorine moieties were condensed via “click chemistry” to generate nonionic hydrophilic fluorinated molecules with unique 19F MR signatures. These were used to fabricate stable liposome formulations for imaging various tissue types. This approach was tailored to exploit the broad spectrum of organic 19F molecular species and to generate probes with distinct 19F MRI signatures for simultaneous assessment of multiple molecular targets within the same target volume.
Public/Granted literature
- US20180154025A1 HYDROPHILIC FLUORINATED MOLECULES FOR LIPOSOMAL 19F MRI PROBES WITH UNIQUE MR SIGNATURES Public/Granted day:2018-06-07
Information query